![]() |
市場調查報告書
商品編碼
2044322
神經美容活性成分市場預測至2034年-按成分類型、功能效果、原料、應用、劑型、最終用戶和地區分類的全球分析Neurocosmetic Active Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Functional Benefit, Source, Application, Delivery Format, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球神經化妝品活性成分市場將達到 11 億美元,並在預測期內以 8.4% 的複合年成長率成長,到 2034 年達到 21 億美元。
神經美容活性成分是一種特殊的化妝品複合成分,其主要功能是透過與皮膚周圍神經網路相互作用而實現的。它們作用於感覺受體、神經肽訊號通道、神經傳導物質釋放機制以及皮膚與大腦之間的雙向通訊軸,從而產生諸如放鬆臉部肌肉、調節壓力性發炎、增強感官愉悅感以及改善皮膚心理健康等美容效果。這些成分包括抑制臉部肌肉收縮引起的皺紋形成的神經肽(如乙醯基六肽-3和盧法西爾)、調節皮膚壓力反應的適應原植物化合物、神經傳導物質前體、海洋來源的感覺生物活性成分以及靶向表皮和真皮中特定受體群的合成神經活性分子。
心理皮膚科與消費者對皮膚-大腦軸的認知
科學界和消費者對心理壓力、情緒狀態和神經傳導物質傳遞之間的心理皮膚學聯繫的認知日益增強,這種聯繫與壓力性痤瘡、酒糟惡化和加速衰老等可見的皮膚健康問題密切相關。這催生了對專門針對皮膚健康管理神經學方面的化妝品成分的需求。臨床證據表明,包括P物質和CGRP在內的皮膚神經肽介導神經源性炎症,而神經源性發炎會導致多種發炎性皮膚病。這些證據為配方研發人員提供了檢驗的神經標靶,可用於開發新一代化妝品活性成分,以滿足以往未被滿足的皮膚科需求。
由於作用機制複雜,因此需證明其療效。
要證明能夠穿透角質層並到達功能相關的皮膚神經受體群的局部化妝品活性成分具有神經活性,需要先進的體外和體內證據生成方案,這顯著增加了神經化妝品成分研發人員的投入時間和成本。可接受的化妝品感官和皮膚狀況聲明與等同於藥品的神經效應聲明之間的監管界限,需要從科學和法律角度進行仔細考慮。日益成熟的化妝品品牌客戶越來越要求第三方機構提供神經化妝品成分功效聲明的獨立可重複性證明,這進一步增加了成分商業化專案的研發成本和時間。
定位為高階抗污染和都會壓力護膚。
都市區對緩解城市生活帶來的神經和生理性皮膚壓力(例如空氣污染引起的神經炎症性疾病、噪音壓力導致的皮質醇對皮膚的影響以及藍光造成的晝夜節律紊亂)的需求日益成長,這為神經美容活性成分在都市健康護膚配方中的應用創造了高階市場機遇。高階都市護膚品牌憑藉其科學嚴謹的多機製配方,能夠獲得顯著的溢價,因此,對於那些能夠解決城市皮膚壓力神經層面問題的差異化神經美容活性成分而言,它們是極具價值的客戶。而這些問題是僅使用抗氧化劑的傳統污染防治配方所無法解決的。
低成本通用植物性適應原供應商之間的競爭
神經美容活性成分市場面臨來自低成本、通用型植物性適應原和植物萃取物供應商的競爭壓力。這些供應商提供價格低廉的通用成分,並宣稱具有模糊的減壓功效,其價格低於經過科學驗證、擁有可靠臨床證據支持的專有神經美容活性成分。尋求經濟有效的減壓方案的化妝品品牌配方師可能會用來自不受監管供應鏈的廉價通用型適應原替代其專有的神經美容活性成分。這可能會降低專業神經美容成分開發者在成分創新方面的投資回報率,並有可能使原本定位為以科學主導的高階活性成分類別淪為商品。
疫情引發的全球壓力和焦慮危機顯著提升了化妝品開發商和品牌對舒緩壓力護膚活性成分的關注度,這些成分能夠改善消費者在疫情封鎖期間因心理壓力而導致的可見肌膚變化。疫情期間及之後,神經美容活性成分原料創新的投資加速成長。疫情後,與壓力相關的肌膚問題結構性增加,以及消費者對身心合一美容產品的濃厚興趣,持續推動著神經美容活性成分市場的發展。
在預測期內,海洋生物活性成分細分市場預計將成為最大的細分市場。
預計在預測期內,海洋生物活性成分細分市場將佔據最大的市場佔有率。這主要歸功於海洋環境中豐富的新型神經活性化合物,例如岩藻聚醣、間苯三酚、海洋膠原蛋白肽和藻類多酚等,這些化合物已被證實具有調節和抗神經發炎作用,能夠影響感覺受體。海洋來源的神經美容成分受益於消費者對「清潔美容」的濃厚興趣、永續採購理念以及海洋生物技術研究不斷湧現的創新發現,這些因素共同支撐了高階化妝品配方中優質成分的定價和品牌故事的差異化。
在預測期內,壓力緩解細分市場預計將呈現最高的複合年成長率。
在預測期內,預計減壓類產品將呈現最高的成長率。這主要得益於全球壓力普遍性的結構性上升,以及消費者對能夠透過調節神經皮膚通路發揮經證實減壓功效的化妝品的持續需求。積極尋求差異化減壓活性成分的配方品牌,正致力於研發具有臨床證據支持的神經化妝品,從而推動了對這些成分的強勁需求。此外,對特定成分與受體相互作用的持續科學檢驗,也使得高階減壓護膚的功效宣稱成為可能,加速了其在高階和精品化妝品市場的商業性化應用。
在預測期內,北美地區預計將佔據最大的市場佔有率,這得益於其作為全球最大的高階化妝品市場的地位、化妝品配方研發人員的高額創新投入,以及消費者對經科學驗證的活性成分資訊的強烈認可。美國在神經美容活性成分的應用方面處於領先地位,這得益於高階品牌的大量研發投入,以及具有影響力的皮膚科醫生群體積極推廣神經美容成分的科學教育。
在預測期內,歐洲預計將呈現最高的複合年成長率。這主要得益於法國、德國、瑞士和英國強大的化妝品原料創新生態系統,以及歐洲化妝品品牌在基於實證的原料故事講述方面發揮的主導作用,從而創造了對經臨床檢驗的神經美容活性成分的高階市場需求。歐洲化妝品產業對以壓力與皮膚關聯為主題的產品研發投入,正在推動該地區原料需求的成長。
According to Stratistics MRC, the Global Neurocosmetic Active Ingredients Market is accounted for $1.1 billion in 2026 and is expected to reach $2.1 billion by 2034 growing at a CAGR of 8.4% during the forecast period. Neurocosmetic active ingredients refer to specialized cosmetic raw material compounds that exert their primary functional activity through interaction with the skin's peripheral neurological network, targeting cutaneous sensory receptors, neuropeptide signaling pathways, neurotransmitter release mechanisms, and the skin-brain bidirectional communication axis to deliver cosmetic benefits including reduced facial tension expression, stress-induced inflammation modulation, sensory pleasure enhancement, and psychodermatological wellbeing improvement. These ingredients encompass neuropeptides, including argireline and leuphasyl, that inhibit facial muscle contraction-driven wrinkle formation, adaptogenic plant compounds modulating skin stress responses, neurotransmitter precursors, marine-derived sensory bioactives, and synthetic neuro-active molecules targeting specific receptor populations in the epidermis and dermis.
Psychodermatology and skin-brain axis consumer awareness
Growing scientific and consumer awareness of the psychodermatological connection linking psychological stress, emotional states, and neurological signaling to visible skin health outcomes, including stress acne, rosacea flares, eczema exacerbations, and accelerated aging, is creating demand for cosmetic ingredients specifically addressing the neurological dimension of skin health management. Clinical evidence demonstrating that cutaneous neuropeptides, including substance P and CGRP, mediate neurogenic inflammation driving multiple inflammatory skin conditions, is providing formulation scientists with validated neurological targets for next-generation cosmetic active ingredient development, addressing previously unmet dermatological needs.
Complex mechanistic claim substantiation requirements
Demonstrating neurological activity of topically applied cosmetic active ingredients through the stratum corneum to reach functionally relevant cutaneous nerve receptor populations requires sophisticated in vitro and in vivo evidence generation programs that substantially increase ingredient development investment timelines and costs for neurocosmetic ingredient developers. Regulatory boundaries separating acceptable cosmetic sensory and skin condition claims from drug-equivalent neurological effect assertions require careful scientific and legal navigation. Independent replication of neurocosmetic ingredient efficacy claims by third-party laboratories is increasingly demanded by sophisticated cosmetic brand clients, adding development cost and timeline to ingredient commercialization programs.
Luxury anti-pollution and urban stress skincare positioning
Urban consumer demand for cosmetic solutions addressing the combined neurological and physiological skin stress consequences of city living, including pollution-induced neurogenic inflammation, noise stress-triggered cortisol skin effects, and blue light circadian disruption, creates a premium application opportunity for neurocosmetic active ingredients in urban wellness skincare formulations. Premium urban skincare brands commanding significant price premiums for scientifically sophisticated multi-mechanism formulations represent high-value ingredient development target customers for differentiated neurocosmetic actives addressing the urban skin stress neurological dimension that conventional antioxidant-only anti-pollution formulations cannot address.
Generic botanical adaptogen competition from low-cost suppliers
The neurocosmetic active ingredient market faces competitive pressure from low-cost generic botanical adaptogen and plant extract suppliers offering inexpensive commodity ingredients with vague stress reduction claims that undercut the pricing of scientifically characterized proprietary neurocosmetic actives with robust clinical evidence packages. Cosmetic brand formulators seeking cost-effective stress relief positioning may substitute proprietary neurocosmetic actives with affordable generic adaptogens from unregulated supply chains, reducing ingredient innovation investment returns for specialty neurocosmetic ingredient developers and commoditizing what are positioned as premium science-led active categories.
The pandemic's global stress and anxiety crisis substantially elevated cosmetic formulator and brand interest in stress-modulating skin care active ingredients that could address the visible skin consequences of psychological distress experienced by consumers during lockdown periods. Ingredient innovation investment in neurocosmetic actives accelerated during and after the pandemic. Post-pandemic, structural elevation of stress-related skin concerns and strong consumer interest in holistic mind-skin beauty products continue to drive neurocosmetic active ingredient market development.
The marine bioactives segment is expected to be the largest during the forecast period
The marine bioactives segment is expected to account for the largest market share during the forecast period, due to the rich diversity of novel neuroactive compounds, including fucoidans, phlorotannins, marine collagen peptides, and algal polyphenols, with documented sensory receptor modulation and anti-neuroinflammatory activity that marine environments provide. Marine neurocosmetic ingredients benefit from strong consumer clean beauty appeal, sustainable sourcing narratives, and the innovative discovery pipeline that marine biotechnology research continues to generate, supporting premium ingredient pricing and brand storytelling differentiation in prestige cosmetic formulations.
The stress reduction segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the stress reduction segment is predicted to witness the highest growth rate, driven by structurally elevated global stress prevalence, creating persistent consumer demand for cosmetic products delivering documented stress relief benefits through neurological skin pathway modulation. Formulation brands actively seeking differentiated neurocosmetic stress modulation actives with published clinical evidence are creating strong ingredient demand pull, and the ongoing scientific validation of specific ingredient-receptor interactions enabling premium stress reduction skincare claim positioning is accelerating commercial adoption across prestige and masstige cosmetic tiers.
During the forecast period, the North America region is expected to hold the largest market share, due to the largest global prestige cosmetic market, high cosmetic formulator innovation investment, and strong consumer receptivity to scientifically positioned active ingredient communication. The United States leads neurocosmetic active ingredient adoption through concentrated prestige brand research and development investment, and influential cosmetic dermatologist communities driving neurocosmetic ingredient science education.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, due to strong cosmetic ingredient innovation ecosystems in France, Germany, Switzerland, and the UK combined with European cosmetic brand leadership in scientific ingredient storytelling that creates premium market demand for clinically validated neurocosmetic actives. European cosmetic industry investment in stress-skin connection product development is driving regional ingredient demand growth.
Key players in the market
Some of the key players in Neurocosmetic Active Ingredients Market include Givaudan SA, BASF SE, Symrise AG, Croda International Plc, DSM-Firmenich, Ashland Global Holdings, Solvay SA, Clariant AG, Evonik Industries AG, Seppic SA, Lucas Meyer Cosmetics, Induchem Group, Sederma Inc., Provital Group, LipoTrue SL, CLR Berlin, and Mibelle Biochemistry.
In March 2026, Givaudan SA launched a patented marine-derived neuropeptide inhibitor active demonstrating 48-hour facial tension reduction and skin stress inflammation modulation validated in a double-blind consumer trial.
In February 2026, Mibelle Biochemistry introduced a novel plant stem cell-derived neurocosmetic active targeting TRPV1 sensory receptor modulation for urban pollution-induced skin hypersensitivity and neurogenic inflammation reduction.
In February 2026, LipoTrue SL released a new neurotransmitter-modulating peptide complex demonstrating synaptogenic activity in skin cells with documented anxiolytic skin receptor effects validated through standardized neurobiological assay protocols.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.